首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1554259

消融设备市场规模、份额、成长分析：按产品、按应用、按最终用途、按地区 - 行业预测，2024-2031 年

Ablation Devices Market Size, Share, Growth Analysis, By Product, By Application, By End use, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月07日 | 出版商:

SkyQuest | 英文 265 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球消融设备市场规模为79.2亿美元，从2023年的86亿美元成长到2031年的179.2亿美元，预计复合年增长率为8.5%。

手术技术在全球范围内经历了重大发展，医疗保健领域也取得了重大进展。这些进步包括采用最先进的筛检、诊断和治疗技术，以及引入尽量减少术后不适的策略。该领域的一个显着发展是微创手术的兴起，由于其优势而变得越来越受欢迎。随着人口老化的增长和慢性疾病变得更加复杂，患者正在寻求负担较轻的治疗方法。微创手术的好处包括减轻疼痛、缩短住院时间和加快復原时间。微创手术的重点是消融，这是一种透过汽化、冷冻、辐射和机械侵蚀等方法从人体器官中去除生物材料的技术。在医疗实践中，消融通常用于以微创方式去除小肿瘤或污染组织。化学消融和射频消融术等技术也用于瞄准和去除受影响的组织。消融术最近越来越受欢迎，因为它比传统的开放性手术侵入性更小，并且为切除肿瘤和组织提供了更舒适的选择。由于癌症和心血管疾病等慢性疾病的增加，预计对消融设备的需求将会成长。

市场概况
射频设备
雷射/光学烧蚀机
- 准分子雷射烧蚀机
- 冷雷射烧蚀机
超音波设备
- 高强度聚焦超音波消融仪
- 体外震波碎石系统
- 磁振造影引导聚焦超音波消融装置
冷冻消融装置
- 组织接触探头
- 组织喷雾探针
- 表皮及皮下冻融装置
电烧灼
- 氩离子/束凝固设备
- 不可逆电穿孔消融仪
微波消融仪
热液消融器
其他的

消融设备市场：依应用分类

市场概况
心血管疾病的治疗
整容整形外科
整形外科治疗
癌症治疗
- 肝癌
- 肾癌
- 摄护腺癌
- 肺癌
- 骨转移
- 乳癌
泌尿系统治疗
妇科治疗
疼痛管理
眼科治疗

消融设备市场：依最终用途分类

市场概况
医院、外科中心、消融中心
门诊手术中心
医疗水疗美容诊所
其他最终用途

消融设备市场：按地区

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Johnson & Johnson（US）
Medtronic（Ireland）
Boston Scientific Corporation（US）
Abbott（US）
AtriCure, Inc.（US）
AngioDynamics（US）
ConMed Corporation（US）
Olympus Corporation（Japan）
Smith+Nephew（UK）
Stryker（US）
Cynosure Lutronic（US）
BioVentus（US）
Merit Medical Systems（US）
Canyon Medical Inc.（US）
Arthrex, Inc.（US）
IceCure Medical（Israel）
Minimax Medical Holding Group（China）
CardioFocus（US）
EDAP TMS（France）
Mermaid Medical（Denmark）
Monteris（Canada）
SonaBlate Corp.（US）
Eco Medical（US）
Surgnova（France）

简介目录

Product Code: SQMIG35A2603

Global Ablation Devices Market size was valued at USD 7.92 billion in 2022 and is poised to grow from USD 8.60 billion in 2023 to USD 17.92 billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031).

Surgical techniques have undergone significant evolution globally, with substantial advancements in the healthcare sector. These advancements range from adopting cutting-edge screening, diagnostic, and treatment technologies to implementing strategies that minimize post-surgical discomfort. A notable development in this area is the rise of minimally invasive surgery, which has become increasingly favored due to its benefits. As the senior population grows and chronic conditions become more complex, patients are seeking less disruptive treatment options. Minimally invasive surgery offers advantages such as reduced pain, shorter hospital stays, and faster recovery times. A key aspect of minimally invasive procedures is ablation, a technique used to remove biological material from human organs through methods like vaporization, freezing, radiation, or mechanical erosion. In medical practice, ablation is typically employed to excise small tumors or contaminated tissues with minimal invasiveness. Techniques such as chemical ablation and radiofrequency ablation are also utilized to target and eliminate affected biological tissues. The popularity of ablation has surged recently due to its less intrusive nature compared to traditional open surgeries, offering a more comfortable alternative for tumor and tissue removal. With the increasing incidence of chronic diseases, including cancer and cardiovascular issues, the demand for ablation devices is expected to grow.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ablation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ablation Devices Market Segmental Analysis

The global Ablation Devices market is segmented based on product, application, end use, and region. Based on product, the market is segmented into Radiofrequency Devices, Laser/Light Ablators, Ultrasound Devices, Cryoablation Devices, Electric Ablators, Microwave Ablators, Hydrothermal Ablators and Others. Based on application, the market is segmented into Cardiovascular Disease Treatment, Cosmetic/Aesthetic Surgery, Orthopaedic Treatment, Cancer Treatment, Urological Treatment, Gynaecological Treatment, Pain Managment, and Ophthalmological Treatment. Based on end use, the market is segmented into Hospitals, Surgical Centers, And Ablation Centers, Ambulatory Surgical Centers, Medical Spas & Aesthetic Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, and MEA.

Drivers of the Global Ablation Devices Market

A significant driver of market growth is the increasing patient preference for minimally invasive procedures over traditional open surgeries. The popularity of minimally invasive treatments has surged due to their advantages, including shorter hospital stays, quicker recovery, and reduced discomfort compared to conventional methods. Additionally, the growing prevalence of atrial fibrillation among the general population is expected to drive the demand for cardiac ablation procedures. Minimally invasive ablation techniques for atrial fibrillation offer high effectiveness, lower risk, and greater patient convenience. Consequently, the growing adoption of less invasive treatment options and advancements in ablation devices are anticipated to significantly boost the ablation devices market in the coming years.

Restraints in the Global Ablation Devices Market

A notable limitation in the market is the absence of effective conventional first-line treatments for conditions such as liver cancer, uterine fibroids, hemorrhagic stroke, and other hemorrhagic disorders. Traditional therapies, including surgery, chemotherapy, and radiation, remain popular due to widespread public familiarity and acceptance. In particular, there is low adoption of newer treatment options in developing countries, coupled with oncologists' hesitation to move away from established methods. This reluctance to embrace advanced treatments impedes the growth of newer therapeutic approaches in these areas.

Market Trends of the Global Ablation Devices Market

Emerging markets in Asia-Pacific, Africa, and Latin America are anticipated to become increasingly attractive due to advancements in ablation technologies, rising demand for minimally invasive treatments, and growing disposable incomes. Additionally, these regions benefit from a substantial population with undiagnosed conditions, rapid urbanization leading to higher chronic disease rates, increased awareness of prostate cancer, and improved government funding for healthcare. These factors are expected to drive market growth and expand opportunities for ablation technologies in these regions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Value Chain Analysis
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Pest Analysis
Porter's Five Forces Analysis
Supply chain analysis
Ecosystem coverage: parent market
Reimbursement scenario
Pricing trend analysis
Trade Analysis

Global Ablation Devices Market by Product

Market Overview
Radiofrequency Devices
Laser/Light Ablators
- Excimer laser ablators
- Cold laser ablators
Ultrasound Devices
- High-intensity focused ultrasound ablators
- Extracorporeal shockwave lithotripsy systems
- Magnetic resonance-guided focused ultrasound ablators
Cryoablation Devices
- Tissue contacts probes
- Tissue spray probes
- Epidermal & subcutaneous cryoablation devices
Electric Ablators
- Argon plasma/beam coagulators
- Irreversible electroporation ablators
Microwave Ablators
Hydrothermal Ablators
Others

Global Ablation Devices Market by Application

Market Overview
Cardiovascular Disease Treatment
Cosmetic/Aesthetic Surgery
Orthopaedic Treatment
Cancer Treatment
- Liver Cancer
- Kidney Cancer
- Prostate Cancer
- Lung Cancer
- Bone Metastasis
- Breast Cancer
Urological Treatment
Gynaecological Treatment
Pain Managment
Ophthalmological Treatment

Global Ablation Devices Market by End Use

Market Overview
Hospitals, Surgical Centers, And Ablation Centers
Ambulatory Surgical Centers
Medical Spas & Aesthetic Clinics
Other End Users

Global Ablation Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ConMed Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith+Nephew (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cynosure Lutronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioVentus (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canyon Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IceCure Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Minimax Medical Holding Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CardioFocus (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EDAP TMS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mermaid Medical (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Monteris (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SonaBlate Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eco Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Surgnova (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments